FEATURE: Will Bayer s Woes Intensify its Current Bioinformatics and Genomic Deals? | GenomeWeb

NEW YORK, Aug. 16 – Bayer’s recent announcement that it would consider merging its drug division even if it meant losing control of the business came as a surprise to many analysts who thought that Bayer, beset by plunging profits and a major drug recall, would seek a merger on the condition that it maintained management control.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.